These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
634 related articles for article (PubMed ID: 19609474)
21. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial. Capizzi R; Landi F; Milani M; Amerio P Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558 [TBL] [Abstract][Full Text] [Related]
22. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg. Gold LS; Cruz A; Eichenfield L; Tan J; Jorizzo J; Kerrouche N; Dhuin JC Cutis; 2010 Feb; 85(2):94-104. PubMed ID: 20349684 [TBL] [Abstract][Full Text] [Related]
23. Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris. Del Rosso JQ J Drugs Dermatol; 2007 Jun; 6(6):616-22. PubMed ID: 17668527 [TBL] [Abstract][Full Text] [Related]
24. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study. Dréno B; Kaufmann R; Talarico S; Torres Lozada V; Rodríguez-Castellanos MA; Gómez-Flores M; De Maubeuge J; Berg M; Foley P; Sysa-Jedrzejowska A; Kerrouche N; Paliargues F; Bettoli V Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995 [TBL] [Abstract][Full Text] [Related]
25. Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne. Kircik L Cutis; 2007 Jul; 80(1 Suppl):10-4. PubMed ID: 17824581 [TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study. Eichenfield LF; Alió Sáenz AB J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562 [TBL] [Abstract][Full Text] [Related]
27. Adapalene/benzoyl peroxide gel 0.3%/2.5% for acne vulgaris. Dréno B; Layton AM; Troielli P; Rocha M; Chavda R Eur J Dermatol; 2022 Jul; 32(4):445-450. PubMed ID: 36301750 [TBL] [Abstract][Full Text] [Related]
28. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial. Poulin Y; Sanchez NP; Bucko A; Fowler J; Jarratt M; Kempers S; Kerrouche N; Dhuin JC; Kunynetz R Br J Dermatol; 2011 Jun; 164(6):1376-82. PubMed ID: 21457209 [TBL] [Abstract][Full Text] [Related]
29. Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability. Ko HC; Song M; Seo SH; Oh CK; Kwon KS; Kim MB J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):245-50. PubMed ID: 19438817 [TBL] [Abstract][Full Text] [Related]
30. A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene. Goreshi R; Samrao A; Ehst BD J Drugs Dermatol; 2012 Dec; 11(12):1422-6. PubMed ID: 23377511 [TBL] [Abstract][Full Text] [Related]
31. Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management. Tanghetti E Cutis; 2009 Nov; 84(5 Suppl):18-24. PubMed ID: 19999189 [TBL] [Abstract][Full Text] [Related]
32. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris. Sagransky M; Yentzer BA; Feldman SR Expert Opin Pharmacother; 2009 Oct; 10(15):2555-62. PubMed ID: 19761357 [TBL] [Abstract][Full Text] [Related]
33. A split-faced, observer-blinded comparison study of topical adapalene/benzoyl peroxide and adapalene in the treatment of Asian acne patients. Kim WJ; Park JM; Ko HC; Kim BS; Kim MB; Song M J Drugs Dermatol; 2013 Feb; 12(2):149-51. PubMed ID: 23377384 [No Abstract] [Full Text] [Related]
34. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris. Thiboutot D; Arsonnaud S; Soto P J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220 [TBL] [Abstract][Full Text] [Related]
35. The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions. Feldman SR; Tan J; Poulin Y; Dirschka T; Kerrouche N; Manna V J Am Acad Dermatol; 2011 Jun; 64(6):1085-91. PubMed ID: 21439678 [TBL] [Abstract][Full Text] [Related]
36. A subgroup analysis to evaluate the efficacy and safety of adapalene-benzoyl peroxide topical gel in black subjects with moderate acne. Alexis AF; Johnson LA; Kerrouche N; Callender VD J Drugs Dermatol; 2014 Feb; 13(2):170-4. PubMed ID: 24509968 [TBL] [Abstract][Full Text] [Related]
37. Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period. Ting W Cutis; 2012 Aug; 90(2):91-6. PubMed ID: 22988653 [TBL] [Abstract][Full Text] [Related]
38. Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability. Fakhouri T; Yentzer BA; Feldman SR J Drugs Dermatol; 2009 Jul; 8(7):657-61. PubMed ID: 19588642 [TBL] [Abstract][Full Text] [Related]
39. Epiduo (adapalene 0.1% and benzoyl peroxide 2.5%) approval in children 9 years and older. Scheinfeld N Skinmed; 2013; 11(5):295-6. PubMed ID: 24340470 [No Abstract] [Full Text] [Related]
40. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study. Hayashi N; Kurokawa I; Siakpere O; Endo A; Hatanaka T; Yamada M; Kawashima M J Dermatol; 2018 Aug; 45(8):951-962. PubMed ID: 29905384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]